Gilead Total Assets vs Total Liab Analysis

0QYQ Stock

92.82 0.27 0.29%

Gilead Sciences financial indicator trend analysis is much more than just examining Gilead Sciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Gilead Sciences is a good investment. Please check the relationship between Gilead Sciences Total Assets and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Gilead Stock please use our How to Invest in Gilead Sciences guide.

Total Assets vs Total Liab

Total Assets vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Gilead Sciences Total Assets account and Total Liab. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Gilead Sciences' Total Assets and Total Liab is 0.93. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Total Liab in the same time period over historical financial statements of Gilead Sciences, assuming nothing else is changed. The correlation between historical values of Gilead Sciences' Total Assets and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Gilead Sciences are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Total Assets i.e., Gilead Sciences' Total Assets and Total Liab go up and down completely randomly.

Correlation Coefficient

0.93

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Assets

Total assets refers to the total amount of Gilead Sciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Gilead Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Gilead Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Gilead Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Gilead Stock please use our How to Invest in Gilead Sciences guide.Tax Provision is likely to drop to about 1.5 B in 2024. Selling General Administrative is likely to drop to about 5 B in 2024

	2020	2021	2023	2024 (projected)
Gross Profit	20.1B	20.7B	23.8B	21.5B
Total Revenue	24.7B	27.3B	31.4B	27.0B

Gross Profit Total Revenue

Gilead Sciences fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Short Term Investments	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Other Current Liab	Other Liab	Net Tangible Assets	Accounts Payable
Total Assets		0.22	0.98	-0.65	-0.44	-0.63	0.29	0.22	-0.35	0.59	0.35	-0.14	0.03	0.28	-0.08	-0.55	0.93	-0.34	0.41	-0.53	0.13	0.27	0.28	-0.25	0.7
Short Long Term Debt Total	0.22		0.27	0.22	0.45	-0.5	-0.28	1.0	0.37	-0.2	-0.27	0.56	-0.57	-0.36	-0.63	-0.64	0.48	0.31	-0.19	0.64	-0.62	-0.25	-0.26	0.27	-0.19
Total Current Liabilities	0.98	0.27		-0.67	-0.47	-0.61	0.2	0.27	-0.4	0.6	0.4	-0.19	0.05	0.33	-0.01	-0.52	0.94	-0.38	0.47	-0.5	0.13	0.38	0.39	-0.35	0.64
Total Stockholder Equity	-0.65	0.22	-0.67		0.73	0.42	0.2	0.22	0.57	-0.58	-0.4	0.45	-0.23	-0.45	0.03	0.46	-0.65	0.46	-0.43	0.78	-0.3	-0.34	-0.61	0.54	-0.55
Retained Earnings	-0.44	0.45	-0.47	0.73		0.3	-0.02	0.45	0.96	-0.92	-0.9	0.93	-0.82	-0.93	-0.51	0.01	-0.34	0.92	-0.89	0.67	-0.85	-0.81	-0.84	0.92	-0.68
Cash	-0.63	-0.5	-0.61	0.42	0.3		-0.03	-0.5	0.38	-0.51	-0.29	0.07	0.01	-0.27	0.47	0.7	-0.75	0.38	-0.35	0.09	-0.04	-0.25	-0.3	0.31	-0.24
Other Assets	0.29	-0.28	0.2	0.2	-0.02	-0.03		-0.28	-0.1	0.17	0.13	-0.07	0.15	0.05	0.39	0.38	-0.02	-0.15	0.09	-0.35	0.26	0.16	-0.21	0.13	0.25
Long Term Debt	0.22	1.0	0.27	0.22	0.45	-0.5	-0.28		0.37	-0.2	-0.27	0.56	-0.57	-0.36	-0.63	-0.64	0.48	0.31	-0.19	0.64	-0.62	-0.25	-0.26	0.27	-0.19
Cash And Short Term Investments	-0.35	0.37	-0.4	0.57	0.96	0.38	-0.1	0.37		-0.92	-0.94	0.95	-0.86	-0.96	-0.53	-0.08	-0.26	0.99	-0.93	0.54	-0.89	-0.9	-0.85	0.96	-0.54
Net Receivables	0.59	-0.2	0.6	-0.58	-0.92	-0.51	0.17	-0.2	-0.92		0.94	-0.82	0.79	0.92	0.4	-0.14	0.5	-0.94	0.95	-0.49	0.82	0.8	0.74	-0.86	0.76
Good Will	0.35	-0.27	0.4	-0.4	-0.9	-0.29	0.13	-0.27	-0.94	0.94		-0.92	0.91	0.98	0.62	0.13	0.25	-0.98	0.99	-0.36	0.91	0.91	0.8	-0.93	0.62
Short Term Investments	-0.14	0.56	-0.19	0.45	0.93	0.07	-0.07	0.56	0.95	-0.82	-0.92		-0.95	-0.96	-0.72	-0.32	-0.01	0.94	-0.89	0.51	-0.95	-0.88	-0.82	0.93	-0.5
Capital Surpluse	0.03	-0.57	0.05	-0.23	-0.82	0.01	0.15	-0.57	-0.86	0.79	0.91	-0.95		0.94	0.74	0.43	-0.12	-0.9	0.87	-0.34	0.99	0.82	0.71	-0.84	0.47
Inventory	0.28	-0.36	0.33	-0.45	-0.93	-0.27	0.05	-0.36	-0.96	0.92	0.98	-0.96	0.94		0.6	0.16	0.19	-0.98	0.97	-0.41	0.93	0.91	0.86	-0.96	0.55
Other Current Assets	-0.08	-0.63	-0.01	0.03	-0.51	0.47	0.39	-0.63	-0.53	0.4	0.62	-0.72	0.74	0.6		0.77	-0.33	-0.56	0.57	-0.36	0.74	0.68	0.42	-0.52	0.3
Other Stockholder Equity	-0.55	-0.64	-0.52	0.46	0.01	0.7	0.38	-0.64	-0.08	-0.14	0.13	-0.32	0.43	0.16	0.77		-0.77	-0.11	0.05	-0.04	0.39	0.29	0.08	-0.07	-0.28
Total Liab	0.93	0.48	0.94	-0.65	-0.34	-0.75	-0.02	0.48	-0.26	0.5	0.25	-0.01	-0.12	0.19	-0.33	-0.77		-0.24	0.33	-0.31	-0.06	0.18	0.28	-0.24	0.55
Total Current Assets	-0.34	0.31	-0.38	0.46	0.92	0.38	-0.15	0.31	0.99	-0.94	-0.98	0.94	-0.9	-0.98	-0.56	-0.11	-0.24		-0.97	0.44	-0.91	-0.92	-0.82	0.95	-0.56
Intangible Assets	0.41	-0.19	0.47	-0.43	-0.89	-0.35	0.09	-0.19	-0.93	0.95	0.99	-0.89	0.87	0.97	0.57	0.05	0.33	-0.97		-0.34	0.86	0.91	0.8	-0.93	0.63
Common Stock	-0.53	0.64	-0.5	0.78	0.67	0.09	-0.35	0.64	0.54	-0.49	-0.36	0.51	-0.34	-0.41	-0.36	-0.04	-0.31	0.44	-0.34		-0.47	-0.36	-0.42	0.39	-0.54
Property Plant Equipment	0.13	-0.62	0.13	-0.3	-0.85	-0.04	0.26	-0.62	-0.89	0.82	0.91	-0.95	0.99	0.93	0.74	0.39	-0.06	-0.91	0.86	-0.47		0.81	0.68	-0.82	0.55
Other Current Liab	0.27	-0.25	0.38	-0.34	-0.81	-0.25	0.16	-0.25	-0.9	0.8	0.91	-0.88	0.82	0.91	0.68	0.29	0.18	-0.92	0.91	-0.36	0.81		0.87	-0.92	0.34
Other Liab	0.28	-0.26	0.39	-0.61	-0.84	-0.3	-0.21	-0.26	-0.85	0.74	0.8	-0.82	0.71	0.86	0.42	0.08	0.28	-0.82	0.8	-0.42	0.68	0.87		-0.92	0.26
Net Tangible Assets	-0.25	0.27	-0.35	0.54	0.92	0.31	0.13	0.27	0.96	-0.86	-0.93	0.93	-0.84	-0.96	-0.52	-0.07	-0.24	0.95	-0.93	0.39	-0.82	-0.92	-0.92		-0.44
Accounts Payable	0.7	-0.19	0.64	-0.55	-0.68	-0.24	0.25	-0.19	-0.54	0.76	0.62	-0.5	0.47	0.55	0.3	-0.28	0.55	-0.56	0.63	-0.54	0.55	0.34	0.26	-0.44

Click cells to compare fundamentals

Gilead Sciences Account Relationship Matchups

Gilead Sciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	63.7B	61.6B	68.4B	68.0B	78.1B	73.0B
Total Current Liabilities	9.8B	11.4B	11.6B	11.2B	12.9B	12.1B
Total Stockholder Equity	21.4B	22.5B	18.2B	21.1B	19.0B	16.6B
Retained Earnings	19.4B	14.4B	16.3B	15.7B	14.1B	13.8B
Cash	17.9B	11.6B	6.0B	7.8B	7.0B	8.2B
Other Assets	3.1B	1.7B	2.9B	2.9B	3.4B	2.9B
Cash And Short Term Investments	30.1B	24.4B	7.4B	7.8B	7.0B	6.7B
Net Receivables	3.6B	4.9B	4.5B	4.8B	5.5B	4.6B
Inventory	922M	1.7B	1.6B	1.5B	1.7B	1.3B
Other Stockholder Equity	85M	(60M)	83M	2M	2.3M	2.2M
Total Liab	42.3B	39.1B	50.2B	46.9B	53.9B	50.2B
Total Current Assets	30.3B	16.0B	14.8B	14.4B	13.0B	19.1B
Intangible Assets	15.7B	13.8B	33.1B	33.5B	38.5B	24.9B
Property Plant Equipment	5.2B	5.6B	5.7B	6.0B	6.9B	5.4B
Other Current Liab	430M	1.3B	2.3B	1.4B	1.6B	1.3B
Other Liab	6.5B	9.5B	9.6B	7.3B	8.4B	8.8B
Net Tangible Assets	4.6B	(23.0B)	(20.7B)	(16.0B)	(14.4B)	(15.1B)
Accounts Payable	713M	844M	705M	905M	1.0B	870.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Gilead Stock Analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Gilead Total Assets vs Total Liab Analysis

Total Assets vs Total Liab

Total Assets vs Total Liab Correlation Analysis

Correlation Coefficient

Total Assets

Total Liab

Gilead Sciences fundamental ratios Correlations

Gilead Sciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Gilead Sciences fundamental ratios Accounts

Also Currently Popular

Additional Tools for Gilead Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Total Current Assets	+ 0.99	Cash And Short Term Investments
Intangible Assets	+ 0.99	Good Will
Property Plant Equipment	+ 0.99	Capital Surpluse
Total Current Liabilities	+ 0.98	Total Assets
Inventory	+ 0.98	Good Will

Total Current Assets	- 0.98	Inventory
Total Current Assets	- 0.98	Good Will
Intangible Assets	- 0.97	Total Current Assets
Net Tangible Assets	- 0.96	Inventory
Inventory	- 0.96	Short Term Investments
Inventory	- 0.96	Cash And Short Term Investments